Skip to main content
. Author manuscript; available in PMC: 2013 Jun 17.
Published in final edited form as: Immunol Res. 2011 Apr;49(0):56–69. doi: 10.1007/s12026-010-8194-6

Figure 2.

Figure 2

Fig. 2A.) Time to death from all causes in the “Day 50” cohort by Opportunistic Infection status. Fig. 2B.) Time to death from OI by presence or absence of severe GvHD. Reproduced with permission from Cytotherapy c2007, Informa Healthcare Journals